Home| Journals | Statistics Online Expert | About Us | Contact Us

[Abstract] [PDF] [HTML] [Linked References]

International Journal of Recent Trends in Science and Technology, ISSN 2277-2812 E-ISSN: 2249-8109

Volume 12, Issue 2, September 2014 pp 303-306

A study of assessment of dyslipidemia in hypertensive patients

Laxmikant Chavan¹, Abraha Hailu²

¹Medical Superintendent, SDH Karjat  410201 Maharastra, INDIA and Ex. Assistant Professor, Department of Internal Medicine, Mekelle University, College of Health Sciences, Ayder Referral Hospital, Mekelle, ETHIOPIA.

2Assistant Professor, Head, Department of Internal Medicine, Mekelle University, College of Health Sciences, Ayder Referral Hospital, Mekelle, ETHIOPIA.

Abstract

Introduction: The metabolic syndrome is a constellation of interrelate risk factors of metabolic origin—metabolic risk factors that appear to directly promote the development of atherosclerotic cardiovascular disease. The most widely recognized of the metabolic risk factors are atherogenic dyslipidemia, elevated blood pressure, and elevated plasma glucose. Aims and objectives: To assess the Dyslipidemia in hypertensive patients as per ATP-3 guidelines. Material and Method: In the present study two groups were formed (hypertensive and control group). Lipid profile of all the selected patients was done and compared. Results: 48% and 32% of hypertensive patients were having borderline high to high cholesterol level. 40% hypertensive subjects were having elevated serum triglyceride levels. 54% of patients belonging to control group had optimal LDL Cholesterol level.44% hypertensive were having VLDL >30. In control group only 6% were having VLDL >30. 92% hypertensive had levels more than 40 whereas in control group 38% had levels more than 40. Conclusion: thus we conclude that there is significant association of Hypertension and Dyslipidemia.